« Previous
Next »
Seminars in Arthroplasty
Volume 20, Issue 4
, Pages 227-229
, December 2009
American College of Chest Physicians Guidelines: Advantages and Disadvantages
References
- Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785
- Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines. (8th edition) Chest. 2008;133:381S–453S
- . Venous thromboembolism (VTE) core measure set. http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/VTE.htmAccessed August 13, 2009
- Failure of the American College of Chest Physicians-1A protocol for Lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty. 2007;22:317–324
- Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty. J Arthroplasty. 2006;21:469–475
- Mandated venous thromboembolism prophylaxis: Possible adverse outcomes. J Arthroplasty. 2008;23(suppl 1):15–19
- Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89:33–38
- Does “excessive” anticoagulation predispose to periprosthetic infection?. J Arthroplasty. 2007;22(suppl 2):24–28
- Predictors of wound infection in hip and knee joint replacement: Results from a 20 year surveillance program. J Orthop Res. 2002;20:506–515
- Factors affecting deep vein thrombosis rate following total knee arthroplasty under epidural anesthesia. J Arthroplasty. 1993;8:133–139
- . The benefit of aspirin chemoprophylaxis for thromboembolism after total knee arthroplasty. Clin Orthop Relat Res. 2006;452:175–180
- Bozic K, Auerbach A, Maselli J, et al: Award paper: Is there a role for aspirin in venous thromboembolism prophylaxis following total knee replacement? Presented at the 17th Annual Meeting of the American Association of Hip and Knee Surgeons, Nov 2-4, 2007, Dallas, TX
- Callaghan J, Warth LC, Hoballah J, et al: Low morbidity low cost DVT prophylaxis in low risk patients undergoing TXA. Presented at the 17th Annual Meeting of the American Association of Hip and Knee Surgeons, Nov 2-4, 2007, Dallas, TX
- Incidence of pulmonary embolism after total knee arthroplasty with low-dose coumadin prophylaxis. Clin Orthop Relat Res. 1993;286:27–31
- Routine use of adjusted low-dose warfarin to prevent venous thromboembolism after total hip replacement. J Bone Joint Surg Am. 1993;75:893–898
- . Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg Br. 1997;79:1037–1038
- The John Charnley award: Prevention of readmission for venous thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 2005;441:56–62
- The Mark Coventry award: Prevention of readmission for venous thromboembolism after total knee arthroplasty. Clin Orthop Relat Res. 2006;452:21–27
- Colwell C, Ritter MA, Froimson MI, et al: Thrombosis prevention in total hip arthroplasty: CECT vs LMWH. Presented at the 75th American Academy of Orthopaedic Surgeons Annual meeting, March 7, 2008, San Francisco, CA
- . Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty. J Bone Joint Surg Am. 1999;81:690–696
- Venous haemodynamics after total knee arthroplasty: Evaluation of active dorsal to plantar flexion and several mechanical compression devices. J Bone Joint Surg Br. 1998;80:1057–1066
PII: S1045-4527(09)00057-1
doi: 10.1053/j.sart.2009.10.005
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Arthroplasty
Volume 20, Issue 4
, Pages 227-229
, December 2009
